表紙:医療用外骨格の世界市場 - 規模、シェア、動向分析、機会、予測:タイプ別、可動性別、コンポーネント別、用途別、地域別(2019年~2029年)
市場調査レポート
商品コード
1249969

医療用外骨格の世界市場 - 規模、シェア、動向分析、機会、予測:タイプ別、可動性別、コンポーネント別、用途別、地域別(2019年~2029年)

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Mobility ; By Component ; By Application ; By Region

出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.40円
医療用外骨格の世界市場 - 規模、シェア、動向分析、機会、予測:タイプ別、可動性別、コンポーネント別、用途別、地域別(2019年~2029年)
出版日: 2023年03月17日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医療用外骨格の市場規模は、2022年の3億2,762万米ドルから2029年までに20億7,240万米ドルに達し、2023年~2029年の予測期間中にCAGRで30.2%の健全な成長が予測されています。市場の主な成長要因は、世界の高齢者人口の増加、自動車、軍事・防衛、建設などのさまざまな業界における医療機器の利用率の上昇、脳卒中の発生率の上昇などです。

当レポートでは、世界の医療用外骨格市場について調査分析し、市場規模と予測、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の医療用外骨格市場の考察

  • 用途バリューチェーン分析
  • DROC分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術の進歩/最近の発展
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の医療用外骨格市場の概要

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
      • パワード外骨格
      • パッシブ外骨格
    • 可動性別
      • 固定式
      • 可動式
    • コンポーネント別
      • ハードウェア
      • ソフトウェア
    • 用途別
      • 脊髄損傷
      • 脳卒中
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第5章 北米の医療用外骨格市場

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
    • 可動性別
    • コンポーネント別
    • 用途別
    • 国別
      • 米国
      • カナダ

第6章 欧州の医療用外骨格市場

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
    • 可動性別
    • コンポーネント別
    • 用途別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他の欧州

第7章 アジア太平洋の医療用外骨格市場

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
    • 可動性別
    • コンポーネント別
    • 用途別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア・ニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • その他のアジア太平洋

第8章 ラテンアメリカの医療用外骨格市場

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
    • 可動性別
    • コンポーネント別
    • 用途別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他のラテンアメリカ

第9章 中東・アフリカの医療用外骨格市場

  • 市場規模と予測(2019年~2029年)
    • 金額
  • 市場シェアと予測
    • タイプ別
    • 可動性別
    • コンポーネント別
    • 用途別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他の中東・アフリカ

第10章 競合情勢

  • 主要企業とそのタイプのリスト
  • 世界の医療用外骨格企業の市場シェア分析(2022年)
  • 競合ベンチマーキング:経営パラメーター別
  • 主な戦略的展開(合併、買収、パートナーシップなど)

第11章 世界の医療用外骨格市場に対するCOVID-19の影響

第12章 企業プロファイル(企業の概要、財務マトリックス、競合情勢、主な人材、主な競合、連絡先、戦略的見通し、SWOT分析)

  • Ekso Bionics
  • ReWalk Robotics
  • PARKER HANNIFIN CORP
  • CYBERDYNE INC.
  • BIONIK
  • Rex Bionics Ltd.
  • B-Temia
  • Bioventus
  • Hocoma
  • Wearable Robotics srl
  • ExoAtlet
  • Meditouch
  • Suit X
  • MarsiBionics
  • Rehab-Robotics Company Limited
  • Myomo Inc.
  • その他の著名な企業

第13章 主な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23215

Global Medical Exoskeleton Market Size Zooming More Than 6X to Reach USD 2.1 Billion by 2029.

Global medical exoskeleton market is flourishing because of rapid adoption of technology advancements to address the healthcare need of aging world population and people with physical disabilities.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global medical exoskeleton market size at USD 327.62 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global medical exoskeleton market size to grow at a robust CAGR of 30.2% reaching a value of USD 2,072.40 million by 2029. Major growth factors of global medical exoskeleton market include growing elderly population across the world, rising rates of medical device utilization in various industries, such as automobile, military, defense, and construction, and increasing stroke incidences. The growing number of patients with physical disabilities worldwide will drive the medical exoskeleton market. The number of people with physical disabilities is rapidly increasing as a result of car accidents, strokes, and serious injuries, which should encourage the market growth. Strokes are more common in the elderly population. According to the United States Census Bureau, the number of Americans aged 65 and up will more than double by 2050, which could boost the demand for medical exoskeleton across the countries. As a result, the demand for rehabilitation is expected to fuel the growth of the medical exoskeleton market. Also, the increasing prevalence of spinal cord injuries (SCI) is likely to increase demand across the global market during the forecast period. However, regulatory challenges for securing approvals for medical is anticipated to restrain the global medical exoskeleton market during the period in analysis.

Global Medical Exoskeleton Market - Overview:

Robotics is an application of engineering aimed at replacing humans with menial duties, whereas exoskeletons are applications of robotics and bio-mechatronics aimed at augmenting humans while performing a variety of tasks. A robotic suit, powered armor, wearable machine, power jacket, and exo-frame or suit are all synonyms for the exoskeleton. The field of exoskeleton systems is constantly evolving in the current context. Exoskeletons are employed in a variety of industries, including military, civilian, and rehabilitation, to boost soldiers' travel and loading capacities, to strengthen an operator's load-handling capabilities, and to improve lost functionality and patient life. It is also used to treat musculoskeletal diseases. It aids physical therapists in training individuals with motor nerve degeneration and motor cognitive limitations. Exoskeletons are also used in rehabilitation, particularly inpatient training and movement. Wearable exoskeletons are gaining popularity due to the high need for assistive technology in the medical profession, specifically to address concerns about an aging society. Other medical issues, such as aiding trauma victims, paraplegics, spinal cord injured individuals, and rehabilitation, are also important.

Impact of COVID-19 on Global Medical Exoskeleton Market

COVID-19 pandemic adversely affected the worldwide economy, disrupting supply and demand chains and increasing unemployment rates, resulting in overall economic uncertainty. According to Ekso Bionics' 2020 annual report, revenue income decreased by 36% in FY2020 compared to FY2019 due to a substantial reduction in medical device sales. Furthermore, according to the annual report, the demand for exoskeleton-related items dropped by 38% at the start of the pandemic, resulting in 61 bookings in 2020 as opposed to 98 bookings in 2019. Also, the pandemic led to a shortage of healthcare workers, which has made it difficult for hospitals and clinics to implement medical exoskeletons that require trained personnel to operate. However, the pandemic had a positive impact due to a surge in the number of patients with respiratory issues, and medical exoskeletons were used to support their respiratory function. Also, the rising emphasis on telemedicine influenced the medical exoskeleton market. As the pandemic limited in-person consultations, telemedicine has developed as an important method for healthcare practitioners to give care remotely. As a result, there was a demand for medical exoskeletons that may be used in telemedicine consultations. Hence, medical exoskeletons with remote monitoring and control capabilities have become increasingly popular.

Global Medical Exoskeleton Market - By Type:

By type, global medical exoskeleton market is bifurcated into Powered Exoskeleton and Passive Exoskeleton segments. The powered exoskeleton segment dominated the exoskeleton market in 2022 owing to the increasing use of powered exoskeleton solutions in numerous industries to improve personal safety and productivity. Furthermore, the advantages of powered technology items include smoother lifting motion, less strain on the worker's body, higher strength, force multiplier, and increased productivity.

Competitive Landscape

Major players operating in global medical exoskeleton market include Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN CORP, CYBERDYNE INC., BIONIK, Rex Bionics Ltd., B-Temia, Bioventus, Hocoma, Wearable Robotics srl, ExoAtlet, Meditouch, Suit X, MarsiBionics, Rehab-Robotics Company Limited, and Myomo Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Medical Exoskeleton Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Medical Exoskeleton Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Exoskeleton Market Insights

  • 3.1. Application Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Number of People with Physical Disabilities
      • 3.2.1.2. Advancement in Technology
    • 3.2.2. Restraints
      • 3.2.2.1. Regulatory Challenges for Securing Approvals for Medical Exoskeletons
    • 3.2.3. Opportunities
      • 3.2.3.1. Introduction of Soft Actuators
    • 3.2.4. Challenges
      • 3.2.4.1. High Equipment Cost
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Exoskeleton Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Powered Exoskeleton
      • 4.2.1.2. Passive Exoskeleton
    • 4.2.2. By Mobility
      • 4.2.2.1. Stationary
      • 4.2.2.2. Mobile
    • 4.2.3. By Component
      • 4.2.3.1. Hardware
      • 4.2.3.2. Software
    • 4.2.4. By Application
      • 4.2.4.1. Spinal Cord Injury
      • 4.2.4.2. Stroke
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Medical Exoskeleton Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Mobility
    • 5.2.3. By Component
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Type
      • 5.2.5.1.2. By Mobility
      • 5.2.5.1.3. By Component
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Type
      • 5.2.5.2.2. By Mobility
      • 5.2.5.2.3. By Component
      • 5.2.5.2.4. By Application

6. Europe Medical Exoskeleton Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mobility
    • 6.2.3. By Component
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Type
      • 6.2.5.1.2. By Mobility
      • 6.2.5.1.3. By Component
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Type
      • 6.2.5.2.2. By Mobility
      • 6.2.5.2.3. By Component
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Type
      • 6.2.5.3.2. By Mobility
      • 6.2.5.3.3. By Component
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Type
      • 6.2.5.4.2. By Mobility
      • 6.2.5.4.3. By Component
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Type
      • 6.2.5.5.2. By Mobility
      • 6.2.5.5.3. By Component
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Type
      • 6.2.5.6.2. By Mobility
      • 6.2.5.6.3. By Component
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Type
      • 6.2.5.7.2. By Mobility
      • 6.2.5.7.3. By Component
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Type
      • 6.2.5.8.2. By Mobility
      • 6.2.5.8.3. By Component
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Type
      • 6.2.5.9.2. By Mobility
      • 6.2.5.9.3. By Component
      • 6.2.5.9.4. By Application

7. Asia-Pacific Medical Exoskeleton Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mobility
    • 7.2.3. By Component
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Type
      • 7.2.5.1.2. By Mobility
      • 7.2.5.1.3. By Component
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Type
      • 7.2.5.2.2. By Mobility
      • 7.2.5.2.3. By Component
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Type
      • 7.2.5.3.2. By Mobility
      • 7.2.5.3.3. By Component
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Type
      • 7.2.5.4.2. By Mobility
      • 7.2.5.4.3. By Component
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Type
      • 7.2.5.5.2. By Mobility
      • 7.2.5.5.3. By Component
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Type
      • 7.2.5.6.2. By Mobility
      • 7.2.5.6.3. By Component
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Type
      • 7.2.5.7.2. By Mobility
      • 7.2.5.7.3. By Component
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Type
      • 7.2.5.8.2. By Mobility
      • 7.2.5.8.3. By Component
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Type
      • 7.2.5.9.2. By Mobility
      • 7.2.5.9.3. By Component
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Type
      • 7.2.5.10.2. By Mobility
      • 7.2.5.10.3. By Component
      • 7.2.5.10.4. By Application

8. Latin America Medical Exoskeleton Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mobility
    • 8.2.3. By Component
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Type
      • 8.2.5.1.2. By Mobility
      • 8.2.5.1.3. By Component
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Type
      • 8.2.5.2.2. By Mobility
      • 8.2.5.2.3. By Component
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Type
      • 8.2.5.3.2. By Mobility
      • 8.2.5.3.3. By Component
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Type
      • 8.2.5.4.2. By Mobility
      • 8.2.5.4.3. By Component
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Type
      • 8.2.5.5.2. By Mobility
      • 8.2.5.5.3. By Component
      • 8.2.5.5.4. By Application

9. Middle East & Africa Medical Exoskeleton Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mobility
    • 9.2.3. By Component
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Type
      • 9.2.5.1.2. By Mobility
      • 9.2.5.1.3. By Component
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Type
      • 9.2.5.2.2. By Mobility
      • 9.2.5.2.3. By Component
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Type
      • 9.2.5.3.2. By Mobility
      • 9.2.5.3.3. By Component
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Type
      • 9.2.5.4.2. By Mobility
      • 9.2.5.4.3. By Component
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Type
      • 9.2.5.5.2. By Mobility
      • 9.2.5.5.3. By Component
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Type
      • 9.2.5.6.2. By Mobility
      • 9.2.5.6.3. By Component
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Type
      • 9.2.5.7.2. By Mobility
      • 9.2.5.7.3. By Component
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Type
      • 9.2.5.8.2. By Mobility
      • 9.2.5.8.3. By Component
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Types
  • 10.2. Global Medical Exoskeleton Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Exoskeleton Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Ekso Bionics
  • 12.2. ReWalk Robotics
  • 12.3. PARKER HANNIFIN CORP
  • 12.4. CYBERDYNE INC.
  • 12.5. BIONIK
  • 12.6. Rex Bionics Ltd.,
  • 12.7. B-Temia
  • 12.8. Bioventus
  • 12.9. Hocoma
  • 12.10. Wearable Robotics srl
  • 12.11. ExoAtlet
  • 12.12. Meditouch
  • 12.13. Suit X
  • 12.14. MarsiBionics
  • 12.15. Rehab-Robotics Company Limited
  • 12.16. Myomo Inc.
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations